Taysha Gene Therapies (TSHA) traded down -1.12 % during a 24 hours period ending at 01:15 AM Central Europe on Tuesday 27th. One Taysha Gene Therapies stock can currently be bought for about USD 4.01 on popular exchanges. Current supply of Taysha Gene Therapies stocks is 325.8 mn. Taysha Gene Therapies has a current market capitalization of USD 1.3 bn and approximately USD 10.3 mn worth of Taysha Gene Therapies was traded on exchanges in the last 24 hours. Since last month end, Taysha Gene Therapies has traded -17.33 % down. Simple moving average of last 200 days is at USD 5.34. The highest price of past 52 weeks was recorded at USD 7.3 on 05/06/2026. 52 weeks low was at USD 3.46 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Cts (CTS) traded down -0.88 % and now trades at USD 53.92. Current market capitalisation for Cts is USD 1.5 bn. Current price/earnings ratio for Cts is 22.41.
Gcs (4991.TW) traded flat 0 % and now trades at TWD 415. Gcs has a market capitalisation of TWD 50.3 bn. Current price/earnings ratio for Gcs is 126.57.
Voyager (VOYG) traded up 5.33 % and now trades at USD 24.78. Voyager has a market capitalisation of USD 1.5 bn.
Safety Insurance (SAFT) traded up 0.12 % and now trades at USD 104.05. Safety Insurance has a market capitalisation of USD 1.5 bn. Current price/earnings ratio for Safety Insurance is 22.34.
Ultragenyx Pharmaceutical (RARE) traded down -1.88 % and now trades at USD 16.08. Ultragenyx Pharmaceutical has a market capitalisation of USD 1.5 bn.
About Taysha Gene Therapies
Taysha Gene Therapies, Inc. is a pharmaceutical company that specializes in developing therapies for the treatment of monogenic diseases of the central nervous system. The company has its operations in Dallas, United States, and serves customers globally. Their website is accessible under www.tayshagtx.com , and they are listed on the Nasdaq stock exchange.
